Biopharmaceutical stocks are taking another serious beating today. Shares of BioMarin Pharmaceutical (NASDAQ: BMRN) fell by as much as 10%, Bristol-Myers Squibb's (NYSE: BMY) stock dipped by 12.7%, and bluebird bio (NASDAQ: BLUE) lost 18.7% of its value in early-morning trading.
Fortunately, all three of these biopharma stocks have bounced off their intraday lows -- at least to a degree. Nonetheless, BioMarin's stock is still down by 6.24%, Bristol's shares are off by 3.24%, and bluebird is trading 11% lower from where it started the day, as of 12:07 p.m. EDT Monday.
Image source: Getty Images.